PEBP1 and neoplasm: The generalized loss of RKIP expression in tumor tissues together with its described capability to modulate pathways driving tumor cell proliferation or an invasive phenotype, warrant a more profound analysis of RKIP-dependent pathways on primary cells in order to determine profile alterations that may influence cellular transformation or promote an aggressive phenotype.